Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry

Pamukkale local dexamethasone cochlear implant study

Also known as: Intracochlear Dexamethasone, Intratympanic Dexamethasone, Local dexamethasone cochlear implant study

Institution-led study

Primary source

Sponsor / Institution

Institution-led study

Program Type

Therapeutic

Modality

Steroid/Anti-inflammatory

Stage

Not applicable

Status

Completed

Target Gene

—

Route / Mode

Intracochlear or intratympanic injection during cochlear implantation

Confidence

88%

Status Confidence

Status needs checking

Evidence Strength

Needs more support

Last Reviewed

2026-06-10

Geography

Turkey

Population

cochlear-implant, adult

Trial IDs

Mechanism

Prospective randomized study comparing intracochlear dexamethasone, intratympanic dexamethasone, and no additional drug during cochlear implantation for cochlear-cell preservation.

Indications

Sensorineural Hearing Loss

Notes

Registry-verified institution-led dexamethasone route-comparison study during cochlear implantation. It is generic local steroid use, not a commercial pipeline product.

Evidence & Sources

1 structured sources

clinicaltrials

Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...

IDs: NCT04397354

Open

Key Events

2020-03-02

Local dexamethasone cochlear implant study started

2022-09-20

Study completed

Clinical Trials (1)